Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-008-0 | CAS number: 552-30-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991-09-16 to 1991-10-07
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-compliant (self-certified) proprietary study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Remarks:
- self-certified including GLP compliance statement
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Benzene-1,2,4-tricarboxylic acid 1,2-anhydride
- EC Number:
- 209-008-0
- EC Name:
- Benzene-1,2,4-tricarboxylic acid 1,2-anhydride
- Cas Number:
- 552-30-7
- Molecular formula:
- C9H4O5
- IUPAC Name:
- 1,3-dioxo-1,3-dihydro-2-benzofuran-5-carboxylic acid
- Details on test material:
- - Name of test material (as cited in study report): trimellitic anhydride
- Physical state: White flake solid
- Lot/batch No.: ATTA 91-35 (TA 1281)
- Stability under test conditions: Stable when stored under recommended conditions
- Storage condition of test material: Room temperature (approximately 22°C)
- Other: The test article was prepared as a 50% (w/v) suspension in corn oil.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- The animals were male and female Sprague-Dawley rats (Crl:CDR BR), approximately 6 weeks of age, purchased from Charles River Breeding Laboratories Inc. (Portage, MI). The rats weighed 130-227 g on arrival. They were acclimatised for at least 1 week and examined to ensure their health and suitability as test subjects. Rats selected for the study were identified by ear tags and cage cards. Purina Rodent Chow 5001 and reverse-osmosis purified water were provided ad libitum. The rats were housed in stainless steel cages suspended over deotized animal cage boards. The animal room average temperature and relative humidity were 22°C and 39%, respectively. Fluorescent lighting was provided on a 12 hour light/dark cycle.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- The test material was prepared as a 50% (w/v) suspension in corn oil. The flakes were first ground using a pestle and mortar, then the test article and corn oil was homogenised with a Polytron. The dosage formulation was stirred continuously whilst being administered at dosing volumes of 4, 7 and 10 mL/kg bw. Formulations were prepared fresh for each group and administered by oral gavage using a glass syringe equipped with a ball-tipped stainless steel needle.
- Doses:
- 2000 mg/kg bw, 3500 mg/kg bw and 5000 mg/kg bw as a 50% (w/v) suspension in corn oil.
- No. of animals per sex per dose:
- 5 animals/sex/dose
- Control animals:
- no
- Details on study design:
- Animals were fasted for approximately 18 hours prior to dosing and for approximately 4 hours after dosing. Body weights were recorded prior to fasting and immediately prior to dosing, then at 7 and 14 days after dosing. Dosage calculations were based on fasted body weights. Rats were observed for clinical signs and mortality for 14 days after dosing. Necropsies were performed on all rats that died during the study, and those that survived to study termination.
- Statistics:
- The calculation method for the determination of the LD50 was based on Miller and Tainter (Proc. Soc. Exp. Bio. Med., 57:261-264, 1944)
Results and discussion
- Preliminary study:
- No preliminary results
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 340 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 740 - 6 410
- Remarks on result:
- other: Mortality incidences were 2 males in the 3500 mg/kg bw group and all animals in the 5000 mg/kg bw group.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 2 030 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 700 - 5 890
- Remarks on result:
- other: Mortality incidences were 2 females in the 2000 mg/kg bw group, 5 females in the 3500 mg/kg bw group and all animals in the 5000 mg/kg bw group.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 730 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 730 - 4 290
- Remarks on result:
- other: Mortality incidences were 2 females in the 2000 mg/kg bw group, 2 males and 5 females in the 3500 mg/kg bw group and all animals in the 5000 mg/kg bw group.
- Mortality:
- The deaths were observed between 1 and 48 hours after administration.
- Clinical signs:
- other: Prominent clinical signs observed included hypoactivity, hypothermia, ataxia, salivation, discolouration around the mouth, wet/coloured inguinal fur, lacrimation, redness around the nose-eyes and discoloured paws. Rales, loss of righting reflex, pale appe
- Gross pathology:
- Treatment related lesions observed at necropsy included thinning of the stomach walls in the 2000 mg/kg bw, stomach ulcerations in two, five and nine rats that died in the 2000 mg/kg bw, 3500 mg/kg bw and 5000 mg/kg bw, respectively, and discoloured areas in the stomach (indicative of haemorrhage and necrosis) seen in the majority of animals administered 3500 and 5000 mg/kg bw .
Distention of the gastrointestinal tract with gas and/or liquid was also present in several animals which died, however, these changes were considered autolytic in nature rather than treatment related. - Other findings:
- No other findings reported.
Any other information on results incl. tables
Table 1: Summary of mortality data
Dose levels (mg/kg bw) |
Number of deaths/group |
||
|
Male |
Female |
Total |
2000 |
0/5 |
2/5 |
2/10 |
3500 |
2/5 |
5/5 |
7/10 |
5000 |
5/5 |
5/5 |
10/10 |
LD50combined sexes |
2730 mg/kg bw with a 95% confidence limits of 1730 - 4290 |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The LD50 of trimellitic anhydride (TMA) is estimated 3340 mg/kg bw in male rats, 2030 mg/kg bw in females and 2730 mg/kg bw in combined sexes. The LD50 is above 2000 mg/kg bw. On this basis, trimellitic acid does not warrant any classification according to Directive 67/548/EEC and Regulation (EC) No 1272/2008.
- Executive summary:
Trimellitic anhydride was administered to three groups of 5 animals/sex at 2000 mg/kg bw, 3500 mg/kg bw and 5000 mg/kg bw. Clinical signs and body weights were recorded over a 14 day post exposure period. All animals that died during the course of the study and all surviving animals were necropsied.
Mortality incidences were 2 females in the 2000 mg/kg bw, 2 males and 5 females in the 3500 mg/kg bw and all animals in the 5000 mg/kg bw. The clinical signs reported included hypoactivity, ataxia, hypothermia, lacrimation, salivation, redness around the nose, discoloration around the mouth, wet/discoloured inguinal fur and discoloured paws. Treatment related lesions observed at necropsy included thinning of the stomach walls in the 2000 mg/kg bw, stomach ulcerations in two, five and nine rats that died in the 2000 mg/kg bw, 3500 mg/kg bw and 5000 mg/kg bw, respectively, and discoloured areas as a sign of haemorrhage and necrosis was also reported in the stomach of several animals in the 3500 and 5000 mg/kg bw dose levels.
Under the conditions of this test, the oral LD50 of trimellitic anhydride for male was 3340 mg/kg with 95% confidence limits of 1740 - 6410 mg/kg bw. The oral LD50 of trimellitic anhydride for female was 2030 mg/kg with 95% confidence limits of 700 - 5890 mg/kg bw. The oral LD50 of trimellitic anhydride for combined sexes was 2730 mg/kg with 95% confidence limits of 1730 - 4290 mg/kg bw. On this basis, trimellitic anhydride does not warrant any classification according to Directive 67/548/EEC and Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.